259. Lecithin-cholesterol acyltransferase deficiency
[
1 clinical trial,
2 drugs（DrugBank:
1 drug),
0 target gene / 0 target pathway ]
Searched query = "Lecithin cholesterol acyltransferase deficiency", "LCAT deficiency", "Fish eye disease"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/20/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollement | Last_Refreshed_ on | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01782027 | October 2012 | 18 March 2019 | Mendelian Reverse Cholesterol Transport Study | A Validation Study Evaluating the Use of 3H-Cholesterol Bound to Albumin as a Method to Assess Reverse Cholesterol Transport in Subjects With Monogenic Diseases Affecting HDL Metabolism | Cholesterol, HDL;Lipid Metabolism, Inborn Errors;Tangier Disease;LCAT Deficiency;Cholesteryl Ester Transfer Protein (CETP) Deficiency | Drug: 3H-cholesterol bound to albumin | University of Pennsylvania | Not recruiting | 18 Years | 75 Years | All | 30 | N/A | United States |